US Stock MarketDetailed Quotes

NWBO Northwest Biotherapeutics

Watchlist
  • 0.440000
  • -0.012000-2.65%
15min DelayClose May 24 16:00 ET
531.60MMarket Cap-6285P/E (TTM)

Northwest Biotherapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
Total revenue
-67.73%284K
14.80%1.93M
-25.46%445K
97.09%406K
-57.86%201K
118.36%880K
67.46%1.68M
597K
-41.14%206K
14.66%477K
Operating revenue
-67.73%284K
14.80%1.93M
-25.46%445K
97.09%406K
-57.86%201K
118.36%880K
67.46%1.68M
--597K
-41.14%206K
14.66%477K
Cost of revenue
Gross profit
Operating expense
15.78%16.03M
-16.59%57.44M
-16.98%15.59M
-10.07%14.23M
-36.14%13.78M
9.10%13.84M
28.22%68.86M
75.86%18.78M
52.17%15.82M
68.26%21.58M
Selling and administrative expenses
15.80%8.09M
-10.92%29.71M
-13.69%8.13M
-13.53%7.03M
-4.63%7.56M
-11.26%6.98M
-0.14%33.35M
45.19%9.42M
22.24%8.13M
7.58%7.93M
-General and administrative expense
15.80%8.09M
-10.92%29.71M
-13.69%8.13M
-13.53%7.03M
-4.63%7.56M
-11.26%6.98M
-0.14%33.35M
45.19%9.42M
22.24%8.13M
7.58%7.93M
Research and development costs
15.76%7.94M
-21.91%27.73M
-20.30%7.45M
-6.41%7.2M
-54.46%6.21M
42.34%6.86M
74.86%35.51M
123.41%9.35M
105.28%7.69M
150.32%13.65M
Operating profit
-21.44%-15.74M
17.38%-55.51M
16.70%-15.14M
11.48%-13.83M
35.65%-13.58M
-5.52%-12.96M
-27.47%-67.18M
-70.27%-18.18M
-55.42%-15.62M
-70.06%-21.1M
Net non-operating interest income expense
-47.81%-1.52M
13.63%-5.24M
-1.72%-1.24M
-10.45%-1.67M
9.08%-1.3M
46.03%-1.03M
-21.09%-6.07M
-5.90%-1.22M
5.74%-1.51M
-77.45%-1.43M
Non-operating interest expense
47.81%1.52M
-13.63%5.24M
1.72%1.24M
10.45%1.67M
-9.08%1.3M
-46.03%1.03M
21.09%6.07M
5.90%1.22M
-5.74%1.51M
77.45%1.43M
Other net income (expense)
-131.45%-1.05M
94.18%-1.85M
71.51%-2.54M
80.38%-3.09M
106.04%431K
13,456.00%3.34M
-113.42%-31.78M
-106.13%-8.9M
-127.50%-15.72M
-140.50%-7.14M
Gain on sale of security
-111.42%-548K
119.41%5.65M
120.62%1.32M
91.37%-1.32M
111.44%804K
1,203.22%4.8M
-112.26%-29.13M
-104.40%-6.4M
-126.56%-15.27M
-139.57%-7.03M
Special income (charges)
-54.19%-2.17M
-100.78%-5.4M
30.77%-1.76M
-287.72%-1.77M
-329.09%-472K
-443.41%-1.41M
-1,530.91%-2.69M
-11,971.43%-2.54M
---456K
19.12%-110K
-Less:Other special charges
54.19%2.17M
100.78%5.4M
-30.77%1.76M
287.72%1.77M
329.09%472K
443.41%1.41M
1,530.91%2.69M
11,971.43%2.54M
--456K
-19.12%110K
Other non- operating income (expenses)
3,309.62%1.67M
-6,460.61%-2.1M
----
----
--99K
---52K
105.10%33K
----
----
----
Income before tax
-71.91%-18.31M
40.40%-62.6M
33.14%-18.92M
43.44%-18.58M
51.30%-14.45M
25.06%-10.65M
-158.64%-105.03M
-121.23%-28.3M
-172.17%-32.85M
-772.74%-29.67M
Income tax
Net income
-71.91%-18.31M
40.40%-62.6M
33.14%-18.92M
43.44%-18.58M
51.30%-14.45M
25.06%-10.65M
-158.64%-105.03M
-121.23%-28.3M
-172.17%-32.85M
-772.74%-29.67M
Net income continuous Operations
-71.91%-18.31M
40.40%-62.6M
33.14%-18.92M
43.44%-18.58M
51.30%-14.45M
25.06%-10.65M
-158.64%-105.03M
-121.23%-28.3M
-172.17%-32.85M
-772.74%-29.67M
Minority interest income
Net income attributable to the parent company
-71.91%-18.31M
40.40%-62.6M
33.14%-18.92M
43.44%-18.58M
51.30%-14.45M
25.06%-10.65M
-158.64%-105.03M
-121.23%-28.3M
-172.17%-32.85M
-772.74%-29.67M
Preferred stock dividends
Other preferred stock dividends
43.80%568K
1.77M
341K
519K
519K
395K
0
0
0
0
Net income attributable to common stockholders
-70.91%-18.88M
38.71%-64.37M
31.94%-19.26M
41.86%-19.1M
49.55%-14.97M
22.28%-11.05M
-158.64%-105.03M
-121.23%-28.3M
-172.17%-32.85M
-772.74%-29.67M
Basic earnings per share
-100.00%-0.02
40.00%-0.06
0.00%-0.02
33.33%-0.02
0.00%-0.01
0.00%-0.01
-147.62%-0.1
-112.50%-0.02
-160.00%-0.03
-200.00%-0.01
Diluted earnings per share
-100.00%-0.02
40.00%-0.06
0.00%-0.02
33.33%-0.02
0.00%-0.01
0.00%-0.01
-66.67%-0.1
0.00%-0.02
-200.00%-0.03
0.00%-0.01
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022
Total revenue -67.73%284K14.80%1.93M-25.46%445K97.09%406K-57.86%201K118.36%880K67.46%1.68M597K-41.14%206K14.66%477K
Operating revenue -67.73%284K14.80%1.93M-25.46%445K97.09%406K-57.86%201K118.36%880K67.46%1.68M--597K-41.14%206K14.66%477K
Cost of revenue
Gross profit
Operating expense 15.78%16.03M-16.59%57.44M-16.98%15.59M-10.07%14.23M-36.14%13.78M9.10%13.84M28.22%68.86M75.86%18.78M52.17%15.82M68.26%21.58M
Selling and administrative expenses 15.80%8.09M-10.92%29.71M-13.69%8.13M-13.53%7.03M-4.63%7.56M-11.26%6.98M-0.14%33.35M45.19%9.42M22.24%8.13M7.58%7.93M
-General and administrative expense 15.80%8.09M-10.92%29.71M-13.69%8.13M-13.53%7.03M-4.63%7.56M-11.26%6.98M-0.14%33.35M45.19%9.42M22.24%8.13M7.58%7.93M
Research and development costs 15.76%7.94M-21.91%27.73M-20.30%7.45M-6.41%7.2M-54.46%6.21M42.34%6.86M74.86%35.51M123.41%9.35M105.28%7.69M150.32%13.65M
Operating profit -21.44%-15.74M17.38%-55.51M16.70%-15.14M11.48%-13.83M35.65%-13.58M-5.52%-12.96M-27.47%-67.18M-70.27%-18.18M-55.42%-15.62M-70.06%-21.1M
Net non-operating interest income expense -47.81%-1.52M13.63%-5.24M-1.72%-1.24M-10.45%-1.67M9.08%-1.3M46.03%-1.03M-21.09%-6.07M-5.90%-1.22M5.74%-1.51M-77.45%-1.43M
Non-operating interest expense 47.81%1.52M-13.63%5.24M1.72%1.24M10.45%1.67M-9.08%1.3M-46.03%1.03M21.09%6.07M5.90%1.22M-5.74%1.51M77.45%1.43M
Other net income (expense) -131.45%-1.05M94.18%-1.85M71.51%-2.54M80.38%-3.09M106.04%431K13,456.00%3.34M-113.42%-31.78M-106.13%-8.9M-127.50%-15.72M-140.50%-7.14M
Gain on sale of security -111.42%-548K119.41%5.65M120.62%1.32M91.37%-1.32M111.44%804K1,203.22%4.8M-112.26%-29.13M-104.40%-6.4M-126.56%-15.27M-139.57%-7.03M
Special income (charges) -54.19%-2.17M-100.78%-5.4M30.77%-1.76M-287.72%-1.77M-329.09%-472K-443.41%-1.41M-1,530.91%-2.69M-11,971.43%-2.54M---456K19.12%-110K
-Less:Other special charges 54.19%2.17M100.78%5.4M-30.77%1.76M287.72%1.77M329.09%472K443.41%1.41M1,530.91%2.69M11,971.43%2.54M--456K-19.12%110K
Other non- operating income (expenses) 3,309.62%1.67M-6,460.61%-2.1M----------99K---52K105.10%33K------------
Income before tax -71.91%-18.31M40.40%-62.6M33.14%-18.92M43.44%-18.58M51.30%-14.45M25.06%-10.65M-158.64%-105.03M-121.23%-28.3M-172.17%-32.85M-772.74%-29.67M
Income tax
Net income -71.91%-18.31M40.40%-62.6M33.14%-18.92M43.44%-18.58M51.30%-14.45M25.06%-10.65M-158.64%-105.03M-121.23%-28.3M-172.17%-32.85M-772.74%-29.67M
Net income continuous Operations -71.91%-18.31M40.40%-62.6M33.14%-18.92M43.44%-18.58M51.30%-14.45M25.06%-10.65M-158.64%-105.03M-121.23%-28.3M-172.17%-32.85M-772.74%-29.67M
Minority interest income
Net income attributable to the parent company -71.91%-18.31M40.40%-62.6M33.14%-18.92M43.44%-18.58M51.30%-14.45M25.06%-10.65M-158.64%-105.03M-121.23%-28.3M-172.17%-32.85M-772.74%-29.67M
Preferred stock dividends
Other preferred stock dividends 43.80%568K1.77M341K519K519K395K0000
Net income attributable to common stockholders -70.91%-18.88M38.71%-64.37M31.94%-19.26M41.86%-19.1M49.55%-14.97M22.28%-11.05M-158.64%-105.03M-121.23%-28.3M-172.17%-32.85M-772.74%-29.67M
Basic earnings per share -100.00%-0.0240.00%-0.060.00%-0.0233.33%-0.020.00%-0.010.00%-0.01-147.62%-0.1-112.50%-0.02-160.00%-0.03-200.00%-0.01
Diluted earnings per share -100.00%-0.0240.00%-0.060.00%-0.0233.33%-0.020.00%-0.010.00%-0.01-66.67%-0.10.00%-0.02-200.00%-0.030.00%-0.01
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg